Inventor · disambiguated record
Jai Hee Moon
Also filed as: MOON JAI-HEE · YOON BYUNG SUN
9 granted patents·8 pending applications·15 citations·filing 2006–2022
80Inventor score
Top patents by PatentIndex Score
17 records- 0178US8518700B2Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Bmi1 and low molecular weight substance, and method for generating induced pluripotent stem cells using the sameYOU SEUNGKWON·Filed 2011·Granted Aug 27, 2013·6 cites·7 claims
- 0276US8586540B2Composition for improving skin conditions using fetal mesenchymal stem cells from amniotic fluidLEE JANG HO·Filed 2010·Granted Nov 19, 2013·8 cites·7 claims
- 0369US11447500B2Thienopyridine derivatives and pharmaceutical composition comprising sameWELLMARKER BIO CO LTD·Filed 2019·Granted Sep 20, 2022·1 cites·15 claims
- 0462US2021292848A1Novel biomarker for predicting sensitiviy to egfr-targeting agent, and use thereofWELLMARKER BIO CO LTD·Filed 2021·Application pending·0 cites
- 0562US2021292849A1Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereofWELLMARKER BIO CO LTD·Filed 2021·Application pending·0 cites
- 0658US11008622B2Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereofASAN FOUND·Filed 2015·Granted May 18, 2021·0 cites·3 claims
- 0756US2020354794A1Method for determining sensitivity to simultaneous inhibitor against parp and tankyraseASAN FOUND·Filed 2020·Application pending·0 cites
- 0854US10683553B2Method for determining sensitivity to simultaneous inhibitor against PARP and TankyraseASAN FOUND·Filed 2016·Granted Jun 16, 2020·0 cites·4 claims
- 0953US2022288043A1Thienopyridine derivatives and pharmaceutical composition comprising sameWELLMARKER BIO CO LTD·Filed 2022·Application pending·0 cites
- 1051US8772031B2Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Oct4 in combination with Bmi1 or its upstream regulator, and method for generating induced pluripotent stem cells using the sameUNIV KOREA RES & BUS FOUND·Filed 2013·Granted Jul 8, 2014·0 cites·1 claims
- 1148US2023172914A1Biomarker-based therapeutic compositionWELLMARKER BIO CO LTD·Filed 2019·Application pending·0 cites
- 1245US11186873B2Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)WELLMARKER BIO CO LTD·Filed 2015·Granted Nov 30, 2021·0 cites·15 claims
- 1345US9752151B2Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredientASAN FOUND·Filed 2014·Granted Sep 5, 2017·0 cites·2 claims
- 1444US2009227023A1DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING ShhYOU SEUNGKWON·Filed 2006·Application pending·0 cites
- 1540US2011159592A1COMPOSITION FOR REPROGRAMMING SOMATIC CELLS TO GENERATE INDUCED PLURIPOTENT STEM CELLS, COMPRISING Oct4 IN COMBINATION WITH Bmi1 OR ITS UPSTREAM REGULATOR, AND METHOD FOR GENERATING INDUCED PLURIPOTENT STEM CELLS USING THE SAMEUNIV KOREA RES & BUS FOUND·Filed 2010·Application pending·0 cites
- 1636US2009246870A1De-differentiation of astrocytes into neural stem cell using nanogYOU SEUNGKWON·Filed 2006·Application pending·0 cites
- 1734US11946934B2Biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereofWELLMARKER BIO CO LTD·Filed 2015·Granted Apr 2, 2024·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Jai Hee Moon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →